Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia

Health Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ataxia (FA) in individuals aged 16 years and above.

Leave a Reply

Your email address will not be published. Required fields are marked *